BRIWAX Original

Medical Conditions Generally Aggravated by Exposure

Kidney disease; Liver disease; Eye disease; Skin disease including eczema and sensitization. Respira tory disease including asthma and bronchitis. Immediate (Acute) Health Effects by Route of Exposure: Inhalation Irritation Can cause moderate respiratory irritation, dizziness, weakness, fatigue, nausea and headache. Inhalation Toxicity Harmful! Can cause systemic damage. (see “Target Organs”) Skin Contact Can cause moderate skin irritation, defatting and dermatitis. Not likely to cause permanent damage. Skin Absorption Harmful if absorbed through the skin. May cause severe irritation and systemic damage. 3.0 HAZARDS IDENTIFICATION CONT’D Eye Contact Contact with the eyes may cause moderate to severe eye injury. Eye contact may result in tearing and red- dening, but not likely to permanently injure eye tissue. Temporary vision impairment (cloudy or blurred vision) is possible. Ingestion Irritation Irritating to mouth, throat, and stomach. Can cause abdominal discomfort, nausea, vomiting and diarrhea. Aspiration of material into the lungs can cause chemical pneumonitis which can be fatal. Ingestion Toxicity Harmful if swallowed. May cause systemic poisoning. Long-Term (Chronic) Health Effects: Carcinogenicity None of the substances have been shown to cause cancer in long term animal studies. Not a carcinogen according to NTP, IARC, or OSHA. Reproductive and No data available to indicate product or any components present at greater than 0.1% may cause birth de- Developmental Toxicity fect. Mutagenicity No data available to indicate product or any components present at greater than 0.1% is mutagenic and genotoxic.